Title: Study of Anemia in Diabetics
Authors: Dr Babita Ghodake, Dr Atul S. Rai, Dr Sharwari Dabhade
DOI: https://dx.doi.org/10.18535/jmscr/v4i12.06
Abstract
Diabetes is the leading cause of chronic kidney disease (CKD) and is associated with excessive cardiovascular morbidity and mortality.1,2 Anaemia is common among those with diabetes and CKD and greatly contributes to patient outcomes.3,4 Observational studies indicate that low Hb levels in such patients may increase risk for progression of kidney disease and cardiovascular morbidity and mortality.5 Controlled clinical trials of anemia treatment with erythropoietin stimulating agents (ESAs) demonstrated improved quality of life (QOL) but have not demonstrated improved outcomes. 6,7 In some trials, ESA treatment for high Hb levels is associated with worse outcomes such as increased thrombosis risk.6,8 Consequently, the U.S. Food and Drug Administration (FDA) and the National Kidney Foundation (NKF) have modified their recommendations regarding anemia treatment for CKD patients.9
The objectives of this review are.
1) To evaluate the presence of anaemia in patients with diabetes mellitus. And
2) To study the effect of anaemia and its complications in diabetes mellitus.
Methods: The present study is a prospective observational study designed to evaluate the presence of anaemia, effect and complications in diabetes mellitus.
References
1. USRDS. United States Renal Data Systems Annual Data Report. Am J Kid Dis 2007; 49 (Suppl. 1): S10–S294
2. Herzog CA, Mangrum JM, Passman R Sudden cardiac death and dialysis patients. Semin Dial 2008;21: 300– 307
3. Vlagopoulos PT,Tighiouart H, Weiner DE, Griffith J, Pettitt D, Salem DN, Levey AS, Sarnak MJ Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease. J Am Soc Nephrol 2005; 16: 3403– 3410
4. Toto RD Heart disease in diabetic patie-nts. Semin Nephrol 2005; 25: 372– 378
5. New JP, Aung T, Baker PG, Yongsheng G, Pylypczuk R, Houghton J, Rudenski A, New RP, Hegarty J,Gibson JM, O'Donoghue DJ, Buchan IE,The high prevalence of unrecognized anaemia in patients with diabetes and chronic kidney disease: a population-based study. Diabet Med 2008; 25: 564– 569
6. Drueke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, Burger HU, Scherhag A, the CREATE Investigato-rs. Normalization of Hb level in patients with chronic kidney disease and anemia. N Engl J Med 2006; 355: 2071– 2084
7. Horl WH, Vanrenterghem Y, Canaud B, Mann J, Teatini U, Wanner C, Wikström B Optimal treatment of renal anaemia (OPTA): improving the efficacy and efficiency of renal anaemia therapy in haemodialysis patients receiving intravenous epoetin. Nephrol Dial Transplant 2005; 20( Suppl. 3): iii25– iii32
8. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D,the CHOIR Investigators.Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355: 2085–2098
9. Fishbane S, Nissenson AR. The new FDA label for erythropoietin treatment: how does it affect Hb target? Kidney Int 2007; 72: 806– 813
10. Mc Clellan W, Aronoff SL, Bolton WK et al, The prevalence of anaemia in patients with chronic kidney disease. Curr Med Res opin 2004; 20:1501-10
11. U.S. Renal Data System, USRDS 2002 Annual data Report: Tlas of End stage Renal Disease in the United States, National Institutes of Health, National Institutes of diabetes and Digestive and Kidney Diseases, Bethseda, MD, 2001
12. Astor BC, Muntner P, Levin A, Eustace JA, Coresh J: Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988–1994). Arch Intern Med 162:1401 –1408,2002
13. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult U.S. population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41 : 1–12,2003
14. LiVecchi M, Fuiano G, Francesco M, Mancuso D, Faga T, Sponton A, Provenzano R, Andreucci M, Tozzo C: Prevalence and severity of anemia in patients with type 2 diabetic nephropathy and different degrees of chronic renal insufficiency. Nepron Clin Pract 105: c62 –c67, 2007
15. Salman MA (2015), Anaemia in patients with Diabetes Mellitus : Prevalence and Progression. General Med 3: 1000162, doi:10.4172/23275146.1000162
16. Ishimura E, Nishizawa Y, Okuno S,et al, diabetes Mellitus increases the severity of anaemia in non dialysed patients with renal failure. J Nephrol 1998:11: 83-6. Inomata H, Itoh m, Imai h, Sato t,Serum erythropoietin levels as a novel marker of the severity of diabetic nephropathy. Nephron 1997:75: 426-9. BritoPL, Fioretto P, Drummond K, et al, Proximal tubular basement membrane width in insulin-dependent mellitus, Kidney Int 1998: 53:754-61
17. Kuriyama S, Tomonari H, Yoshida H, Hashimoto T, Kawaguchi Y, Sakai O Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients. Nephron 1997; 77: 176– 185
18. Gouva C, Nikolopoulos P, Ioannidis JP,Siamopoulos KC . Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int 2004; 66: 753– 760
19. Rossert J, Levin A, Roger SD, Hörl WH, Fouqueray B, Gassmann-Mayer C, Frei D, McClellan WM .Effect of early correction of anemia on the progression of CKD. Am J Kidney Dis 2006; 47: 738– 750
20. Ritz E, Laville M, Bilous RW, O'Donoghue D, Scherhag A, Burger U, de Alvaro F ; Anemia Correction in Diabetes Study Investigators. Target level for Hb correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) Study. Am J Kidney Dis 2007; 49: 194– 207
21. Cody J, Daly C, Campbell M, et al; Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients. Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003266.; Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003266.
22. Besarab A, Soman S; Anemia management in chronic heart failure: lessons learnt from chronic kidney disease. Kidney Blood Press Res. 2005;28(5-6):363-71. Epub 2006 Mar 7.; Kidney Blood Press Res. 2005;28(5-6):363-71. Epub 2006 Mar 7.
23. Meguid El Nahas A, Bello AK; Chronic kidney disease: the global challenge. Lancet. 2005 Jan 22-28;365(9456):331-40.; Lancet. 2005 Jan 22-28;365 (9456):331-40.